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Abstract. 
 
Ras is a universal eukaryotic intracellular
protein integrating extracellular signals from multiple
receptor types. To investigate its role in the adult cen-
tral nervous system, constitutively activated V12-Ha-
Ras was expressed selectively in neurons of transgenic
mice via a synapsin promoter. Ras-transgene protein
expression increased postnatally, reaching a four- to
ﬁvefold elevation at day 40 and persisting at this level,
thereafter. Neuronal Ras was constitutively active and
a corresponding activating phosphorylation of mitogen-
activated kinase was observed, but there were no
changes in the activity of phosphoinositide 3-kinase, the
phosphorylation of its target kinase Akt/PKB, or ex-
 
pression of the anti-apoptotic proteins Bcl-2 or Bcl-X
 
L
 
.
Neuronal Ras activation did not alter the total number
of neurons, but induced cell soma hypertrophy, which
resulted in a 14.5% increase of total brain volume. Cho-
line acetyltransferase and tyrosine hydroxylase activi-
ties were increased, as well as neuropeptide Y expres-
sion. Degeneration of motorneurons was completely
prevented after facial nerve lesion in Ras-transgenic
mice. Furthermore, neurotoxin-induced degeneration
 
of dopaminergic substantia nigra
 
 
 
neurons and their stri-
atal projections was greatly attenuated. Thus, the Ras
signaling pathway mimics neurotrophic effects and trig-
gers neuroprotective mechanisms in adult mice. Neu-
ronal Ras activation might become a tool to stabilize
donor neurons for neural transplantation and to protect
neuronal populations in neurodegenerative diseases.
Key words: Ras • neuron • transgenic • protection •
mouse
 
Introduction
 
The Ras/mitogen-activated protein kinase (MAPK)
 
1
 
 (ex-
tracellular signal–regulated kinase [ERK]) pathway is an
evolutionary conserved signaling pathway found in all eu-
karyotic cells, including yeast (Marshall, 1996). In mam-
mals, the Ras family comprises Ha-Ras, Ki-Ras, and
N-Ras that are all lipid-anchored proteins in the inner face
 
of membranes, cycling between the inactive GDP-bound and
the signaling competent GTP-bound conformation. A net-
work of upstream mechanisms converge onto the activa-
tion of Ras by using distinct types of Ras GTPase activat-
ing proteins (GAPs) or Ras-guanine nucleotide exchange
factors (Wittinghofer, 1998) that respond to extracellular
ligand–receptor triggered signaling cascades and intracel-
lular second messengers (Reuther and Der, 2000). The
mammalian RAS-guanine nucleotide exchange factor son
of sevenless (mSOS1,2) is activated by receptor tyrosine
kinases, whereas the guanine nucleotide release factors
(Ras-GRF1,2) and the guanine nucleotide release protein
are involved in calcium channel–mediated or G-protein–
coupled receptor mechanisms. Conversely, a family of dis-
tinct types of Ras-GAP proteins regulate GTP hydrolysis:
besides 120Ras-GAP and GAP1, neurofibromin (NF)-1, a
protein that is deficient in patients with von Reckling-
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Abbreviations used in this paper:
 
 Chat, choline acetyltransferase; ERK,
extracellular signal–regulated kinase; GAD, glutamic acid decarboxylase;
GAP, GTPase activating protein; IRES, internal ribosomal entry site;
 
lacZ, 
 
b
 
-galactosidase; MAPK, mitogen-activated protein kinase;
 
 
 
MPP
 
1
 
,
1-methyl-4-phenylpyridinium; MPTP, 
 
N
 
-methyl-4-phenyl-1,2,3,6-tetrahydro-
pyridine; NF, neurofibromin; NMR, nuclear magnetic resonance; NPY, neu-
ropeptide Y; P, postnatal; PI 3-kinase, phosphoinositide 3-kinase; PKB,
phosphoinositide-dependent protein kinase; TG, transgene; TH, tyrosine hy-
droxylase; wt, wild-type; 6-OHDA, 6-hydroxydopamine. 
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hausen disease type 1, is regulated by lipids (Bollag and
McCormick, 1991; Lockyer et al., 1999). The brain-specific
synGAP is negatively regulated by intracellular calcium
concentrations (Kennedy, 1998).
In cultured neural cells, the intracellular functions of Ras
strictly depend on the cell type investigated: in transformed
astrocytes proliferation depends on Ras (Guha et al., 1997),
yet in nerve growth factor responsive–PC12 pheochromocy-
toma tumor cells, Ras has been shown to stop proliferation
and induce neurite outgrowth (Bar-Sagi and Feramisco,
1985; Noda et al., 1985). Moreover, neuronal survival has
been demonstrated to depend on Ras, as shown by the in-
tracellular application of function blocking anti-Ras F
 
ab
 
fragments into cultured embryonic neurons in vitro (Bora-
sio et al., 1993) or inactive Ras (N17 Ras) (Xue et al., 2000).
Consistently, cultured neurotrophin-deprived embryonic
neurons derived from dorsal root ganglia, superior cervical
ganglion, nodose ganglia, ciliary ganglia, or spinal cord are
rescued from apoptosis by the intracellular application of
activated Ras protein or cDNA (Borasio et al., 1989; Nobes
et al., 1996; Weng et al., 1996; Xue et al., 2000)
How can Ras activation direct specific downstream
functions in neurons? The major pathways induced by Ras
are Raf-1/B-raf/MAPK, Ral-GDS/phospholipase D/Rho,
and phosphoinositide 3-kinase (PI 3-kinase)/Akt-1(phos-
phoinositide-dependent protein kinase [PKB]) (Katz and
McCormick, 1997). The latter signaling branch has been
shown to promote survival in many neuronal systems
(Williams and Doherty, 1999). In addition to PI 3-kinase,
MAPK (ERK) activation is necessary for neuronal sur-
vival, but this pathway may regulate distinct apoptotic sig-
naling cascades (Xue et al., 2000). In cultured cerebellar
neurons, MAPK (ERK) activates the ribosomal Rsk-
kinase, which, in turn, phosphorylates and thereby inacti-
vates the proapoptotic activity of Bad (Bonni et al., 1999).
The latter belongs to the Bcl-2 family of apoptosis-regulat-
ing proteins, forming homotypic or heterotypic dimers.
An in vivo function of Ras in the intact nervous system
has been implicated from genetically induced deficiencies:
expression of a dominant-negative mutant of c-Raf in-
creased apoptosis during early development of the retina
(Pimentel et al., 2000). Furthermore, inactivation of the
neuronal-specific Ras-guanine nucleotide release factor 1
in mice resulted in an impairment of long-term potentia-
tion in the amygdala (Brambilla et al., 1997). Conversely,
mice deficient in Ha-Ras showed an enhanced long-term
potentiation at the CA1 Schaffer colaterals of the hippo-
campus (Manabe et al., 2000). In NF-1 gene knock-out
mice, spatial learning deficiencies are found (Silva et al.,
1997), and in patients suffering from von Recklinghausen
disease type 1, cognitive functions are impaired. Interest-
ingly, nuclear magnetic resonance (NMR) measurements
showed that in these patients the brain volume is increased
probably due to a relative change in grey matter volume
(Moore et al., 2000). Although the mechanism of this brain
expansion is not known, it has been suggested that NF de-
ficiency results in delayed apoptosis. Indeed, cultured pe-
ripheral neurons from mouse embryos with a targeted dis-
ruption of the NF-1 gene are able to survive in the absence
of neurotrophic supply (Vogel et al., 1995).
However, the general applicability of the concept of
Ras-mediated neuronal survival has been challenged be-
cause, in contrast to superior cervical ganglion neurons,
 
NGF-mediated survival of sympathetic chain neurons is
completely uncoupled from Ras activity (Borasio et al.,
1993; Markus et al., 1997). Here, we expressed constitu-
tively activated Ha-Ras selectively in neurons by using the
neuronal promoter for the synapsin I gene, allowing us to
directly investigate the effects of enhanced Ras activity on
neuronal survival postnatally. Moreover, we asked if neu-
ronal Ras activation could mimic typical neurotrophic
effects, such as neuronal hypertrophy, induction of neu-
ropeptide Y (NPY), or increase in neurotransmitter syn-
thesizing enzyme activities.
 
Materials and Methods
 
Establishment of the Transgene and Transgenic 
Mouse Lines
 
The 5
 
9
 
 nontranslated regions of the human 
 
Ha-Ras
 
 (Capon et al., 1983)
and the rat 
 
Synapsin I
 
 (Sauerwald et al., 1990) genes were fused. The 3
 
9
 
flanking region of the 
 
Ha-Ras
 
 gene, including its polyadenylation signal,
was removed and substituted with a fragment containing internal riboso-
mal entry site (
 
IRES)/LacZ
 
 (Kalnins et al., 1983; Ghattas et al., 1991). A
linear 10.1-kb DNA fragment, without vector sequences, was recovered
and was suitable for mouse embryo manipulation.
Pronucleus DNA injections and embryo transfers were carried out ac-
cording to standard procedures. 15-
 
m
 
g DNA from tail biopsies of each
progeny aged 3 wk were restricted with KpnI, separated on 1.1% agarose
gels, blotted to nylon membranes, and hybridized to a radioactively la-
beled 
 
Ras
 
 probe. Detected 1.9-kb DNA fragments represented 1.6 kb of
the 
 
Synapsin I 
 
promoter and 0.3 kb of the 
 
Ha-Ras
 
 gene at their connec-
tion point, indicating transgene specificity. Outbred lines B6CBF
 
1
 
,
B6CBF
 
1
 
xMF
 
1
 
, and HimOF
 
1
 
xMF
 
1
 
 were used as embryo donors and recipi-
ents. Founders were further bred with lines HimOF
 
1
 
, C57BL/6 (Institute
for Animal Breeding and Genetics, University of Veterinary Medicine,
Vienna, Austria), and NMRI (Central Institute for Laboratory Animal
Breeding, Hannover, Germany).
Lines 46 and 50 were crossed back to NMRI background. They contained
one integration site each with multiple transgene integrants. Whereas line 46
was bred to homozygocity, putative homozygous animals of line 50 could not
be obtained. Ras-transgenic mice (syn Ras-TG) of lines 46 and 50 developed
normally and did not show obvious behavioral differences to wild-type (wt)
littermates.
 
Western Blots
 
Tissue was lysed in ice-cold lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM
NaCl, 40 mM NaF, 5 mM EDTA, 5 mM EGTA, 1% [vol/vol] NP-40, 0.1%
sodiumdesoxycholate, 0.1% SDS, 10 
 
m
 
g/ml aprotinin, 1 mM PMFS) using
a 1-ml Dounce homogenizer. After centrifugation (13,000 
 
g
 
, 15 min, 4
 
8
 
C),
the supernatants were collected. The protein concentration was deter-
mined using the DC protein assay (Bio-Rad Laboratories). Equal
amounts of protein were separated on 12% polyacrylamide gels, as de-
scribed by Laemmli. After blotting to 0.2-
 
m
 
m nitrocellulose (Schleicher &
Schuell), the blots were blocked with 5% dry milk in TBST (10 mM Tris-
HCl, pH 7.6, 150 mM NaCl, 0.05% Tween 20). The immunoreactive bands
were detected using the indicated antibodies, horseradish peroxidase–con-
jugated secondary antibodies (Sigma-Aldrich) and the enhanced chemilu-
minescence substrate detection kit (Amersham Pharmacia Biotech). The
following primary antibodies were used: anti–Ha-Ras (OP23; Calbio-
chem), anti–pan-Ras (OP40; Calbiochem), anti–phospho-MAPK (9106S;
New England Biolabs), anti–synapsin I, anti–phospho-Akt (9271S; New
England Biolabs, Inc.), anti–Bcl-2 (clone 7; Signal Transduction Labora-
tories); and anti–Bcl-X
 
L 
 
(clone 4; Signal Transduction Laboratories).
 
Glutathione-S-transferase–Ras-binding Domain Fusion 
Protein Pulldown Assay and PI 3-kinase Assay
 
Precipitation of GTP-Ras was performed essentially as described previ-
ously (de Rooij and Bos, 1997). For the determination of PI 3-kinase ac-
tivity, tissues were Dounce homogenized on ice in lysis buffer (1% NP-40,
140 mM NaCl, 20 mM Tris-HCl, 1 mM MgCl
 
2
 
, 1 mM CaCl
 
2
 
, 1 mM
Na
 
3
 
VO
 
4
 
, 10% glycerol, 1 mM PMSF, 10 
 
m
 
g/ml aprotinin, at pH 7.4). After
clearing the lysate by centrifugation, the protein concentration was deter- 
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mined using the Bio-Rad DC protein assay kit. 400 
 
m
 
g of protein, in a vol-
ume of 500 
 
m
 
l, was used for immunoprecipitation with either 10 
 
m
 
g anti-
pTyr (PY20; Transduction Laboratories) or 10 
 
m
 
g anti-Ras mAb Y13-259
plus 5 
 
m
 
g anti–rat IgG. The associated PI 3-kinase activity was determined
as described previously (Virdee et al., 1999).
 
Primary Neuronal Cultures
 
Embryonic brains (embryonic day [E]14) were dissected and the midbrain
was transferred to a tube containing MPBS
 
2
 
/
 
1
 
 (10 mM Hepes-NaOH, pH
7.4, 137 mM NaCl, 2.7 mM KCl, 8 mM Na
 
2
 
HPO
 
4
 
, 1.5 mM KH
 
2
 
PO
 
4
 
, 10
mM glucose, 1 mM sodium pyruvate, 1 mg/ml BSA, 2 mM glutamax
[Sigma-Aldrich], 6 
 
m
 
g/ml DNase I, 5 
 
m
 
g/ml phenol red, 100 U/ml penicil-
lin, 100 
 
m
 
g/ml streptomycin, 5.8 mM MgCl
 
2
 
). After incubation with trypsin
(0.25%, 15 min, 37
 
8
 
C) (GIBCO BRL), the tissue was washed twice with
DME/
 
1
 
5 (containing 2 mM glutamax, 10% heat-inactivated fetal calf se-
rum, 100 U/ml penicillin, 100 
 
m
 
g/ml streptomycin, 37.5 
 
m
 
g/ml insulin, 5
mM glucose, 10 mM Hepes-NaOH, pH 7.4, in DME [GIBCO BRL]) and
twice with MPBS
 
2
 
/
 
1
 
. The tissue was dissociated by using a pipette tip, and
seeded to polyornithin-coated 3.5-cm culture dishes with grid (Nunc) con-
taining 1.5 ml DME/
 
1
 
 5. The cells from one embryo were plated on two
dishes. After 24 h, the serum containing DME/
 
1
 
5 was removed, the cells
were washed three times with PBS
 
1
 
/
 
1
 
 and 1.5 ml of B18 medium (modified
from Brewer and Cotman, 1989), and the cells were prepared lacking cata-
lase, reduced glutathione, and superoxide dismutase. Cells were cultured
at 37
 
8
 
C in 10% CO
 
2
 
. Cells were treated either with 150 
 
m
 
M 6-hydroxy-
dopamine (6-OHDA) for 90 min after 6 d in vitro or with 1 
 
m
 
M 1-methyl-
4-phenylpyridinium (MPP
 
1
 
) for 36 h after 4 d in vitro
 
.
 
 Dopaminergic neu-
rons were detected using a primary tyrosine hydroxylase (TH) antibody
(1017381; Roche Diagnostics), a biotin-conjugated secondary antibody
(B8774; Sigma-Aldrich), and extravidin-FITC (Sigma-Aldrich).
 
TH and Choline Acetyltransferase (Chat) Assay
 
The TH assay was performed as described (Bostwick and Le, 1991). For
the Chat assay, different brain regions were dissected and the tissues were
homogenized by sonication in 5 mM Tris-acetate, pH 7.4, and 0.1% Triton
X-100 (vol/vol). The lysate was cleared twice by centrifugation, and an ali-
quot of the supernatant was removed for determination of the protein
content. Equal amounts of the lysate were assayed for Chat activity (Fon-
num, 1975). The linearity of the enzymatic reactions was verified with dif-
ferent amounts of lysate.
 
Facial Nerve Axotomy, Histochemistry, Western Blot 
Analysis, and Facial Motorneuron Plane Determination
 
Five synRas-TG and five wt littermates, both 10 wk old, were subjected to
transection of the right facial nerve. Mice were anesthetized with 1–1.5%
isoflurane in a 70:30 nitrous oxide/oxygen (vol/vol) mixture. A nerve seg-
ment was removed to avoid contact of the nerve endings. Because cell bod-
ies of motorneurons degenerate very slowly after axonal transection (Kou
et al., 1995), mice were analyzed at 24 d after lesion. After cardial perfusion
with 4% paraformaldehyde, brains were postfixated, immersed in 30% su-
crose, frozen and cut into 20-
 
m
 
m frontal sections, and then followed by
Nissl staining of every third section. Facial motorneuron counting of
stained sections was performed by nucleolus identification. Plane size de-
termination of 100 facial motorneurons from all the mice per group was
performed by image analysis system MCID M4 from Image Research, Inc.
 
Cortical Volume, Numerical Density, and Number of 
Cortical Neurons
 
Cortical volume was calculated from the cortical cross-sectional areas ob-
tained by planimetry on serial coronal sections (final magnification: 50
 
3
 
)
throughout the entire length of the cortex. Numerical neuronal density
was determined by the dissector method (Sterio, 1984). Measurements
were taken on semithin sections (final magnification: 500
 
3
 
) throughout
the cortical depth in five randomly located samples of the frontal, parietal,
and occipital cortex. The total number of neurons was estimated from the
mean numerical neuronal density and the total cortical volume.
 
Determination of Dopamine after In Vivo MPTP 
Lesion, as well as in Unlesioned Mice
 
Eight synRas-TG and eight wt adult littermates were treated twice with
30 mg/kg (subcutaneous) 
 
N
 
-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
 
(MPTP, obtained as the hydrochloride salt; RBI) at an interval of 72 h.
They were killed together with 11 synRas-TG and 10 wt untreated adult
littermates by decapitation 21 d after the second MPTP injection. Striata
were dissected, weighed, and homogenized (Branson sonifier B12) in 2 ml
0.15 M chloroacetic acid containing 75 mg/liter EDTA and 200 ng/ml
 
a
 
-methyl-dihydroxyphenylalanine, as an internal standard. The homoge-
nate was adjusted to pH 2.9 using 2 N NaOH and centrifuged at 40,000 
 
g
 
for 10 min. The supernatants were frozen overnight and recentrifuged be-
fore quantification of dopamine by HPLC with electrochemical detection,
as described previously (Waldmeier et al., 1993).
 
In Situ Hybridization and Anatomical and 
Morphometric Analysis
 
For in vivo magnetic resonance imaging measurements, five synRas-TG
and five wt adult littermates were analyzed on a 4.7 tesla 30-cm bore
Bruker DBX (Bruker), according to a published method (Allegrini and
Sauer, 1992) adapted for mice.
For histochemical analysis, mice were killed (overdose of Nembutal, 60
mg/kg body weight i.p.) and perfusion-fixed, as described previously
(Obst and Wahle, 1995). A surface view of each brain was drawn at 16
 
3
 
final magnification with a camera lucida. To process wt and synRas-TG
brains at the same time, the hemispheres were paired, embedded in Tissue
Tek, frozen, cut in 30-
 
m
 
m-thick serial sections, and processed for free-
floating in situ hybridization, as described previously (Obst and Wahle,
1995; Wahle et al., 2000). For detection of the Ras-TG transcript, a 827-bp
region of the lacZ cDNA cloned into pBS SK was used to generate digox-
igenin UTP–labeled antisense riboprobes (Roche). Furthermore, ribo-
probes against glutamic acid decarboxylase (GAD) mRNA and NPY
mRNA were employed (Wahle et al., 2000). 
 
b
 
-Galactosidase (lacZ) staining
of fixed-brain sections (in 2% paraformaldehyde/0.2% glutaraldehyde, 30
min at 4
 
8
 
C) was performed using a 5-bromo-4-chloro-3-indolyl-
 
b
 
-
 
D
 
-galac-
topyranoside (X-gal)–staining solution. The morphometric analysis was
carried out on thionin-stained brain sections of pairs of mice (siblings of
one wt and one synRas-Tg) aged postnatal day (P) 13 and 40, as well as 2
and 6 mo. Somata of large pyramidal neurons of neocortical layer V of
motor and somatosensory cortex and Purkinje cells of the cerebellum
were outlined with a camera lucida at 1,000
 
3
 
 magnification. Drawings
were digitalized, and a somatic area in square micrometer was determined
with an AutoCAD system for at least 150 somata of every population,
which were then statistically compared using a nonparametric test. Soma
sizes were fed into size-frequency histograms.
 
Results
 
Neuronal Expression of Constitutively Active Ras in 
Neurons Leads to an Increase in Postnatal Cortical 
Brain Volume Without Affecting Neuronal
Cell Number
 
The synapsin I promoter was used to drive the selective
expression of V12-Ha-Ras in postmitotic neurons (Sauer-
wald et al., 1990; Hoesche et al., 1993; Lietz et al., 1998)
and minimize the risk of a deregulated cell number or tu-
mor formation (Sweetser et al., 1997; Holland et al., 2000).
The transgene encoded for a dicistronic mRNA, which di-
rects the synthesis of two separate proteins, V12-Ha-Ras
and LacZ (Fig. 1 A), and was tested for its Ras activity by
transfection and induction of fiber outgrowth in PC12 cells
(data not shown).
In the resulting heterozygous syn-Ras-TG mice (line 50),
the levels of activated Ha-Ras (Ras-TG) protein were very
low in the embryo, as revealed by Western blots (not
shown) using antibodies selectively recognizing Ha-Ras,
but not N-Ras or Ki-Ras protein. The major increase in
V12-Ha-Ras expression occurred postnatally in the cortex
of synRas-TG mice, which start to rise at P4, elevate three-
fold by P13, and reach four- to fivefold basal levels by P40
(Fig. 1 B). In wt littermates, endogenous Ha-Ras increased
only moderately during postnatal development. There was 
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no detectable increase in Ras-TG protein in the cerebel-
lum of synRas-TG mice (Fig. 1 B). A second line (line 46)
was investigated and showed comparatively low Ras-TG
expression levels in total brain (not shown). Unless other-
wise stated, the results derive from using heterozygous line
50 with wt littermates as controls.
LacZ activity was used to detect the presence of the dicis-
tronic transgenic mRNA. Fig. 1 C shows a horizontal sec-
tion through a lacZ-stained hemisphere of a wt mouse brain
at 6 mo old compared with that of a synRas-TG mouse. The
cortex of the synRas-TG mouse is clearly enlarged. It is
wider in the medio-lateral direction and extends further
caudally, covering more of the tectum than the wt cortex.
The larger cortex has slightly displaced the cerebellum.
Blue-labeled (lacZ-positive) neurons are evident mainly in
the cortex and hippocampus. Cellular analysis of lacZ activ-
ity indicated that the Ras-TG expression was always re-
stricted to neurons. The latter were distinguished from glia
cells by smooth, rounded nuclei with a large clear nucleolus.
Ras-TG expression was detected in the claustrum and
amygdala, and neuronal subsets in the olfactory bulb, sep-
 
tum, Broca band, preoptic area, anterior and midline tha-
lamic nuclei, tegmentum including substantia nigra, but not
in sensory thalmic nuclei (ventrobasal complex and genicu-
late nuclei) or the tectum (data not shown).
To quantify in vivo the increase in brain volume seen in
the fixed slices, a morphometric evaluation was performed
by NMR imaging using slices of 1-mm thickness (Fig. 1 D).
The volume of the intact cortex increased by 12.7% from
145.2 
 
6 
 
3.4 
 
m
 
l to 163.6 
 
6 
 
3.8 
 
m
 
l (
 
n
 
 
 
5
 
 5, 
 
P
 
 
 
,
 
 0.01), and the
total brain volume increased by 14.5% from 388.7 
 
6 
 
5.7 
 
m
 
l
to 444.1 
 
6 
 
20.6 
 
m
 
l (
 
n
 
 
 
5
 
 5, 
 
P
 
 
 
,
 
 0.05), respectively. Brain
volume expansion in synRas-TG mice could have arisen
from increased neuronal cell numbers or hypertrophy of
individual neurons. Therefore, we determined the neu-
ronal cell numbers in the cortex of synRas-TG mice by
applying the dissectors method to serial semithin sections
of five randomly located samples of the frontal, parietal,
and occipital cortex (Sterio, 1984). The number of cortical
neurons remained unchanged (wt, 6.942 
 
6 
 
0.782 
 
3
 
 10
 
6
 
,
 
n
 
 
 
5
 
 5; synRas TG, 7.077 
 
6 
 
0.782 
 
3
 
 10
 
6
 
, 
 
n
 
 
 
5 
 
5), resulting
in a decreased numerical density from 80.3 
 
6 
 
6.32 (
 
3
 
10
 
3
Figure 1. Generation of Ras-transgenic mice: developmental expression of
constitutively activated Ras and increased brain volume in adult mice. (A)
Schematic diagram of the bicistronic transgene construct. The Ras-TG ex-
pression was driven by the neuron-specific promoter of the synapsin I gene.
The structural genes of the construct consisted of the gene for constitutively
activated  V12-Ha-Ras and the lacZ gene. An “internal ribosomal entry
site” (IRES) is located downstream of the Ras stop codon. The bicistronic
mRNA generated by this construct is terminated at the polyadenylation site
of LacZ. Synapsin I promoter was from Rattus norvegicus; V12-Ha-Ras, hu-
man  Val12–Ha-Ras oncogene (R. Jaggi, Inselspital Bern, Bern, Switzer-
land); IRES of encephalomyocarditis virus (J.E. Majors, Washington Uni-
versity School of Medicine, St. Louis, MO); LacZ was from Escherichia
coli. (B) Developmental Ha-Ras expression in various brain regions and at
different ages of Ras-transgenic (synRas-TG) mice and wt littermates. Ho-
mogenates of brain cortices or cerebella derived from synRas-TG mice and
wt littermates were analyzed by Western blotting using an antibody recog-
nizing endogeneous and activated transgenic Ha-Ras. Ras-TG expression
was hardly detectable prenatally. In the cortex, there was a rapid postnatal
increase reaching a 4.2-fold expression of activated Ras-TG, relative to en-
dogeneous Ha-Ras at 40 d. Only moderate postnatal Ha-Ras increases
were seen in wt cortex or in cerebella of wt or synRas-TG mice. Data are
the means of two independent experiments, as obtained from densitometric
measurements. (C) Horizontal sections of paired brain hemispheres de-
rived from wt (left) or synRas-TG (right) mice after fixation and X-gal
staining. Note the intense expression of the transgene in the region of neu-
ronal cell somata of the hippocampus and also in the cortex (black arrows).
The cortical brain volume is enlarged, leading to a caudal displacement of
the cerebellum (compare white arrows). Bar, 1.8 mm. (D) Total brain vol-
ume and cortical brain volume are enlarged as determined from 13 contigu-
ous coronal slices. Morphometric evaluation of wt (n 5 5) or synRas-TG
(n 5 5) mice was performed by using NMR imaging and a semiautomatic
imaging software on a Silicon Graphics Indy computer.Heumann et al. Constitutive Activation of Neuronal Ras (41) 1541
mm23 in wt) to 66.74 6 5.76 (3103 mm23, P , 0.05) in
synRas-TG.
Brain Region–Specific Expansion of Neuronal Cell 
Soma Diameter
The size-frequency histogram of cross-sectional areas of the
layer V pyramidal neurons in the motor and somatosensory
cortex showed a significant shift to larger soma areas, in-
cluding size classes above the normal range at 6 mo old ani-
mals (P # 0.0001) (Fig. 2 A). This neuronal hypertrophy
was developmentally regulated, corresponding to the neu-
ronal Ras-TG expression levels. At P4, changes were barely
detectable, i.e., differences were not significant, whereas, at
P13, the increases in soma areas were highly significant
(P # 0.0001) (data not shown). Neuronal hypertrophy and
cortical expansion were most prominent in the frontal or
parietal cortex (Fig. 2 C). In the cerebellum, the cross-sec-
tional areas of the individual Purkinje neurons were not
changed in their size distribution (Fig. 2 B).
Significant (P # 0.0001) increases in cortical soma area
in layer V pyramidal neurons was also found in line 46 at 6
mo old.
Constitutive Activation of Ras and MAPKs (ERK1 and 
ERK2), but Not PI 3-kinase and Akt/PKB
To test whether the Ras-TG protein was active in neurons,
we captured active GTP-Ras selectively with a peptide de-
rived from Raf kinase (de Rooij and Bos, 1997). A major
Ras activity was found in extracts of the hippocampus and
cortex, but only low levels were detected in the cerebellum
of synRas-TG mice. In wt littermates, the basal activity of
endogenous Ras was hardly detectable under these experi-
mental conditions (Fig. 3, second row). Because chronic
treatment of responsive PC12 cells with NGF increases syn-
apsin I synthesis (Romano et al., 1987), we tested if neu-
ronal Ras-TG activity regulates endogenous synapsin levels
in the brain. Fig. 3 A shows that the synapsin levels were not
different between synRas-TG mice and wt littermates in all
regions investigated. Moreover, the Ras-TG expression pat-
tern reflected the endogeneous synapsin promoter activity,
with low expression in the cerebellum and high levels in hip-
pocampus or cortex, indicating that Ras-TG activity does
not regulate the endogeneous synapsin I promoter.
As expected from the increased Ras activities in synRas-
TG mice, phosphorylation of MAPKs (ERK-1 and/or
ERK-2) was constitutively elevated in all three brain re-
gions without any changes in MAPK protein expression
(Fig. 3 A). The differential increase in phosphorylation of
ERK-1 or ERK-2 was especially pronounced in the hip-
pocampus and cortex where mainly ERK 1 was activated
in all cases tested (n 5 3).
Besides the MAPK pathway, Ras activates the catalytic
subunit of PI 3-kinase subtypes as a downstream target
Figure 2. (A) Size-frequency distributions of cortical, hippocam-
pal, and cerebellar neurons. Size-frequency distribution of large
pyramidal neurons of layer V in the motor and somatosensory cor-
tex. Note the shift to larger areas, giving rise to new large diameter
size classes. (B) Size-frequency distribution of Purkinje cells of the
cerebellum. No changes in Purkinje cell soma sizes are observed.
(C) Cross-section through the parietal cortex demonstrating the
expansion of the cortical size in synRas-TG mice. Bars, 100 mm.The Journal of Cell Biology, Volume 151, 2000 1542
1999). Fig. 4 shows that the staining intensity and the den-
sity of cortical NPY-expressing neurons clearly increased
throughout the cortex, despite cortical expansion (from 54
to 80 cells/mm2 in sagital sections, P # 0.01). In contrast to
neocortex, NPY mRNA expression appeared to remain
identical in hilus interneurons in the hippocampus and in
neostriatal interneurons (not shown). The staining inten-
sity and density of GAD (Fig. 4) or parvalbumin mRNAs
(not shown) were not affected.
The motorneurons of the facial nucleus were investi-
gated in more detail. In situ lacZ–mRNA hybridization re-
vealed that in the facial nucleus region the typical large di-
ameter motorneurons were clearly lacZ positive (Fig. 5
A). No positive glial cells were found throughout the brain
(not shown). As a functional consequence of the Ras-TG
expression, we found a 25.6% (P , 0.001, n 5 100) in-
crease in the cross-sectional area of the motorneuron so-
mata (Fig. 5 B). Similarly, in the weak Ras-TG–expressing
mouse line 46, an attenuated, yet significant, increase in
cross-sectional area of the motorneuron somata was found
(P , 0.005, n 5 143, data not shown). Finally, we investi-
gated if the Ras-TG activity might regulate the basal activ-
ity of Chat in motorneurons, as it was found in the septum.
The Chat activity per facial nucleus was indeed elevated
by 39% (n 5 3) (Fig. 5 B, insert), suggesting an increased
Chat activity per motorneuron, because their number re-
mained unchanged in the synRas-TG mice.
Figure 3. Effects of neuronal Ras-TG expression on major signal trans-
duction pathways. (A) Ha-Ras expression: crude brain lysates were sep-
arated by SDS-PAGE and blotted on nitrocellulose. Ha-Ras expression
was detected with a Ha-Ras–specific antibody. Note the increased levels
of Ha-Ras protein in cortical and hippocampal brain lysates (synRas-
TG). No overexpression of Ha-Ras was found in the cerebellum of syn-
Ras-TG mice. GTP-Ras levels: GTP-Ras was precipitated from crude
lysates using glutathione–Sepharose loaded with a fusion protein con-
sisting of glutathione-S-transferase and the Ras-binding domain of Raf.
The affinity precipitates were separated by SDS-PAGE and blotted on
nitrocellulose. The amount of signaling active GTP-bound conforma-
tion of Ras proteins was detected using a pan-Ras antibody. Transgenic
V12-Ha-Ras expression results in a major increase of GTP-Ras in the
cortex and hippocampus, but only an attenuated increase is observed in
the cerebellum. Endogenous synapsin I expression: in adult cerebellum,
the relative levels of Synapsin expression are low compared with cortex
and hippocampus. Note that the Ras activity in synRas-TG mice does
not regulate the endogenous Synapsin levels. MAPK phosphorylation:
crude brain lysates were separated by SDS-PAGE, blotted on nitrocel-
lulose, and MAPK phosphorylation was detected using an antibody spe-
cific for MAPK (ERK1 and ERK2) phosphorylated on the activation-
competent threonine and tyrosine. In synRas-TG mice, MAPK tyrosine
phosphorylation in neurons is permanently enhanced, though protein
levels (ERK1 and ERK2) are not affected (see below). MAPK phos-
phorylation is enhanced most prominently in the hippocampus, but only
moderately in the cerebellum, thus, corresponding to the different syn-
Ras-TG expression levels. In the cortex, we observe a more selective
ERK1 over ERK2 phosphorylation. MAPK—total protein content:
equal amounts of protein were loaded in each slot, resulting in similar
signals for total amounts of ERK1 or ERK2. PI 3-kinase activity: the
levels of phosphatidylinositol 3-phosphate (PI[3]P) reaction products
were determined in coimmunoprecipitates using either anti-pTyr antibodies or anti-Ras monoclonal antibody 13-259. Neither the phos-
photyrosine-associated, nor the Ras-associated, PI 3-kinase activity was altered. Akt (PKB) phosphorylation: crude brain lysates were
separated by SDS-PAGE, blotted on nitrocellulose, and phosphorylation of the PI 3-kinase target Akt was detected using an antibody
specific for Akt phosphorylated on serine 473. The phosphorylation of Akt is not altered by the Ras-TG activity in neurons. (B) Levels
of Bcl-2 and Bcl-XL are not altered by the Ras-TG activity in Western blots, as determined by antibodies to Bcl-2 or Bcl-XL.
(Rodriguez-Viciana et al., 1996; Walker et al., 1999). How-
ever, PI 3-kinase activity remained unchanged in brain
homogenates of wt compared with synRas-TG litter-
mates. Consistently, the levels of phosphorylations of the
PI 3-kinase target, Akt-1/PKB (Franke et al., 1995), also
remained unchanged (Fig. 3 A, bottom row). Since Bcl-2
or Bcl-XL have been previously shown to be regulated by
neurotrophins and MAPKs (Liu et al., 1999), their respec-
tive protein levels were investigated. These remained un-
changed in synRas-TG mice in cortex and hippocampus,
regions of high transgene expression (Fig. 3 B).
Enhanced Chat or TH Activities and Increased 
Neuropeptide Y Expression
Besides induction of neuronal hypertrophy, neurotrophic
actions include the regulation of neurotransmitter synthe-
sizing enzymes, such as Chat or TH. Specific Chat activity
in homogenates containing the septal region from the
basal forebrain of synRas-TG mice was 89% higher than
in homogenates of wt littermates (942 6 181 pmol/mg/min,
n 5 6 versus 498 6 149 pmol/mg/min, n 5 9, P , 0,001).
TH activity was elevated by 30.6 6 31% (n 5 5, P , 0.05)
in the mesencephalic forebrain region containing the
dopaminergic neurons of the substantia nigra.
Next, we asked if the activated Ras-TG also affects the
neurochemical properties of cortical inhibitory interneu-
rons known to express TrkB-receptors (Gorba and Wahle,Heumann et al. Constitutive Activation of Neuronal Ras (41) 1543
Ras-TG Expression in Motorneurons of the Facial 
Nucleus Completely Prevents Their Degeneration after 
Nerve Lesion
To test whether the Ras activation not only prevents em-
bryonic apoptosis (see Introduction), but also promotes
protection against lesion-induced neuronal degeneration,
we performed facial nerve lesions in young-adult mice (10
wk old). There was on average a 34% reduction in cell
number of wt mice, whereas there was no reduction (3%,
not significant) in the synRas-TG littermates, as shown by
counting the number of nucleoli-containing neurons in ev-
ery third section of the facial nuclei from five mice each
(Fig. 6, B and C). Morphologically, neurons appeared
healthy on the lesioned side, with no signs of degeneration
or shrinkage in synRas-TG mice (Fig. 6 A).
Ras-TG Expression Attenuates Neurotoxic Insults by
6-OHDA, MPP1, and MPTP in the Substantia Nigra
We next investigated whether the Ras-TG was expressed
in the dopaminergic neurons of the substantia nigra of the
synRas-TG mice. Fig. 7 A shows an example of a TH-
expressing neuron of the substantia nigra that was Ras-
TG–positive. We then asked if the Ras-TG expression
could induce protective mechanisms against the neuronal-
type–specific toxins 6-OHDA or MPP1 (Lotharius et al.,
1999). Mesencephalic embryonic cultures containing TH-
positive neurons were established and neurons were al-
lowed to mature for a period of 5 d. Treatment with 6-OHDA
for 90 min or MPP1 exposure for 36 h reduced the number
of TH-positive neurons to 36 or 25% of untreated controls,
respectively. In cultures of synRas-TG mice, the loss was
partially prevented resulting in a 48 or 34% enhancement
of survival after 6-OHDA or MPP1 treatment (Fig. 7 B).
We also tested the striatal projection area of dopaminer-
gic substantia nigra neurons. In unlesioned animals, there
was a 22% increased level of dopamine in synRas-TG
mice compared with wt littermates (Fig. 7 C). After two
consecutive applications of MPTP, dopamine levels were
reduced from 10336 6 1489 ng/g (n 5 10) to 4029 6 335
ng/g (n 5 8) in wt and from 12599 6 1461 ng/g (n 5 11) to
7459 6 1572 ng/g (n 5 8) in synRas-TG mice, thus indicat-
ing a subtantial protection.
Discussion
To investigate the physiological role of the proto-oncogene
Ras in the adult mammalian nervous system, constitutively
activated V12-Ha-Ras was expressed postnatally in the
brain of transgenic mice. By using the synapsin I promoter,
expression of the Ras-TG was restricted to neurons, giving
rise to healthy transgenic mice with a normal life span.
In the synRas-TG mice, we observed pronounced neu-
ronal hypertrophy, one of the earliest described neu-
rotrophic effects in embryonic chick dorsal root ganglion
neurons and in sympathetic neurons (Levi-Montalcini,
1987). This hypertrophy was present in several populations
of Ras-TG–expressing neurons, i.e., in pyramidal cells of
the cortex and in N7 motorneurons of the nucleus facialis.
Because the Ras oncogene promotes tumors in cell cycle–
Figure 4. In situ mRNA determina-
tion of cDNAs coding for NPY and
GAD. Thionin staining (Thionin)
of a cross-section through the cor-
tex with layers I–VI is shown, as in-
dicated for wt (top) or synRas-TG
(bottom) mice. Bar, 150 mm. The
density and intensity of NPY
mRNA–expressing neurons is up-
regulated throughout the cortex of
synRas-TG mice (NPY, top and
bottom). Bar, 100 mm. However,
GAD cDNA expression is not af-
fected (GAD, top and bottom).
Bar, 100 mm. Note the increased
cross-sectional length of the total
cortical layer from the pia mater to
the borderline layer VI between wt
(z720  mm) and synRas-TG mice
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competent cells of transgenic mice (Sinn et al., 1987; Chin
et al., 1999), an effect on brain cell number of synRas-TG
mice could not be excluded. However, we found that—
especially in frontal and parietal cortical regions—neu-
ronal density was decreased, but neuronal numbers were
unchanged. This suggests that Ras-TG expression occurred
at functionally relevant levels only in fully differentiated
neurons whose numbers were not determined by precursor
cell division or developmentally regulated cell death. In-
creased brain size due to cellular hypertrophy (megen-
cephaly) has also been described in a spontaneous mouse
mutant (Donahue et al., 1996). Furthermore, in humans,
unilateral megencephaly (hemimegalencephaly) occurs as
an uncommon sporadic nonfamilial congenital dysplastic
abnormality of the central nervous system, but the mecha-
nisms of neuronal cell size regulation are not known (Bos-
man et al., 1996). Interestingly, in wing cells of Drosophila,
Ras activity has been shown to promote hypertrophy that
is mediated in part by enhanced expression of dmyc
(Prober and Edgar, 2000).
Our finding that activities of neurotransmitter-synthe-
sizing enzymes regulated by neurotrophic factors, such as
Chat activity of the septal or nucleus facialis regions
(Gnahn et al., 1983) and the TH activity of the substantia
nigra (Hagg, 1998), are increased in synRas-TG mice fits
with the notion that Ras activation in neurons could
mimic neurotrophic actions. Similarly, brain-derived neu-
rotrophic factor stimulates NPY synthesis, and, during de-
velopment, NPY mRNA is transiently increased in cortical
interneurons, reaching maximal levels at z30 d postnatally
and is then downregulated (Obst and Wahle, 1995). The
same developmental profile is displayed by organotypic
thalamocortical cocultures. An early “postnatal” applica-
tion of NT4/5 prevents the developmental downregulation
(Wahle et al., 2000). Moreover, blocking spontaneous
electrical activity also downregulates NPY mRNA (Wirth
et al., 1998). Thus, Ras could mimic neuronal activity, re-
sulting in a maintenance of elevated NPY mRNA levels in
the neocortex of adult synRas-TG mice. In PC12 cells,
such an increase in TrkB-mediated NPY protein ex-
pression is sensitive to blockade by the MEK-inhibitor
PD98059, suggesting a role of the MAPK signaling path-
way (Williams et al., 1998).
MAPKs (ERKs) are phosphorylated after direct binding
of Raf kinases to activated Ras. In addition, some subtypes
of PI 3-kinase have been shown to be direct effectors of
GTP-bound Ras (Rodriguez-Viciana et al., 1996; Rubio et
al., 1997), and PI 3-kinase is a preferred effector of the Ha-
Ras isotype used in the synRas-TG mice (Yan et al., 1998).
Activation of the PI 3-kinase/Akt-1 (PKB) pathway has
been shown to phosphorylate and, thereby, inactivate cell
death regulatory proteins (Biggs et al., 1999; Brunet et al.,
1999). However, in contrast to our recent results on the
rapid increase of PI 3-kinase in response to NGF activation
in peripheral neurons (Virdee et al., 1999), constitutive ac-
tivation of Ras did not reveal any changes in PI 3-kinase
activity. The levels of the phosphorylation of the down-
stream kinase PKB/Akt remained equally unaffected in
synRas-TG mice. Thus, the phenotype of synRas-TG mice
appears to be independent of a major PI 3-kinase activa-
tion in cerebellum, hippocampus, and cortex. Interestingly,
PI 3-kinase–independent neuronal survival pathways have
been described recently, suggesting that PI 3-kinase activa-
tion may not be the sole mechanism of preventing neu-
ronal cell death (Vogelbaum et al., 1998; Virdee et al.,
1999; Williams and Doherty, 1999).
One of the major motivations to establish this synRas-
TG mouse model was to investigate the possible role of
Ras activity in lesion-induced degeneration of the adult
nervous system. It has been shown previously that in cul-
Figure 5. Characterization of Ras-transgenic facial motorneurons. (A) Ras-TG
expression in motorneurons of the facial nucleus in adult mice (6 mo old). (a and
b) Low-power photomicrographs of coronal sections through the brainstem of a
synRas-TG animal (a) and a wt littermate (b). At the level of the genu of the fa-
cial nerve, hybridization with lacZ mRNA reveals intense signals in N7 motor-
neurons and in subsets of neurons in other brainstem structures in the synRas-
TG, but not the wt mouse. (c and d) Higher magnification of the facial nucleus at
a more posterior level in the synRas-TG animal reveals intensely lacZ mRNA–
expressing neurons. The Ras-TG expression varies between the individual neu-
rons, and the reaction product may extend into primary dendrites (arrow head).
No signals were observed in glia cells. Bars: (a and b) 200 mm; (c) 50 mm; (d) 20
mm. (B) Size-frequency distribution of facial motorneurons. The average facial
motorneuron size is enlarged in synRas-TG mice. Insert: Chat activity in facial
nuclei of synRas-TG mice and wt littermates. Expression of Ras-TG protein in
facial motorneurons results in a significant increase in Chat activity.Heumann et al. Constitutive Activation of Neuronal Ras (41) 1545
tures of embryonic neurons ligand-independend survival is
achieved by intracellular application of activated Ras in
chick dorsal root ganglia neurons, in superior cervical gan-
glion neurons, or in spinal motorneurons (Borasio et al.,
1989; Nobes et al., 1996; Weng et al., 1996; Mazzoni et al.,
1999). Our finding that constitutively activated Ras in neu-
rons completely prevented axotomy-induced degeneration
of adult facial motorneurons shows that the activation of
the Ras pathway promotes protective functions in vivo.
Survival of motorneurons is also enhanced by expression
of Bcl-2 in transgenic mice and in Bax knock out mice be-
cause axotomy-induced motorneuron death was prevented
(Martinou et al., 1994; Deckwerth et al., 1996). In our sys-
tem, considering the lack of changes in levels of Bcl-2 or
Bcl-XL, together with the lack of activation of PKB/Akt,
we assume that an as yet unidentified downstream target
of Ras, other than the Bcl-2 family of proteins, may be in-
volved in the Ras-mediated neuronal rescue.
In addition to motorneurons, dopaminergic neurons of the
substantia nigra were investigated, because they serve as a
model of neurons affected in Parkinson’s disease. 6-OHDA
and MPP1 were used as toxins that are thought to be specific
for neurons carrying the dopamine transporter. Although the
mechanism by which MPP1 causes neuronal degeneration
appears to be distinctly different (Lotharius et al., 1999), the
adverse effects of both types of toxins could be attenuated in
dopaminergic neurons of synRas-TG mice. Interestingly,
suppression of Ras activity in PC12 cells rendered them more
sensitive to toxic radicals (Guyton et al., 1996), and, similarly,
in rat sympathetic neurons, NGF-induced suppression of rad-
ical formation was dependent on the concommittent activa-
tion of MAPK (Dugan et al., 1997).
Figure 6. Protection of facial motorneurons from axotomy-induced degeneration. (A) Representative Nissl-stained sections of axoto-
mized mice. The ipsilateral section of the wt mouse shows loss of facial motorneurons compared with the contralateral section, whereas
the facial motorneuron number of the synRas-TG mouse remains equal on both sides. Arrowheads indicate well-preserved motorneu-
rons with nucleoli in lesioned synRas-TG mice. Bar, 50 mm. (B) The number of facial motorneurons per section. Facial motorneurons of
one out of three sections were counted. The first section is determined by the appearance of the first counted facial motorneuron. For
better visualization, the ipsilateral distribution curve was centered within the contralateral distribution curve. Determination of wt fa-
cial motorneuron numbers reveals severe axotomy-induced degeneration along the total ipsilateral nucleus length, which cannot be de-
tected in the synRas-TG mice. (C) The number of counted facial motorneurons per nucleus. Facial motorneurons of one out of three
sections were counted. Total numbers of facial motorneurons per nucleus were not extrapolated. Analysis of counted facial motorneu-
ron numbers reveals full protection of facial motorneurons from axotomy-induced degeneration by the transgene.The Journal of Cell Biology, Volume 151, 2000 1546
In summary, we present a model of a neuroprotective
mechanism promoted by constitutive activation of Ras in
adult central nervous system neurons. It is now possible to
test if neural stem cells derived from synRas-TG mice can
be isolated, cultured, and transplanted to result in stabi-
lized differentiated neurons due to the Ras-TG expression
in the adult mouse brain. The success of transplants of
dopaminergic embryonic mesencephalic neurons into Par-
kinson’s patients has been shown to depend on the preser-
vation of TH activity of the transplant (Wenning et al.,
1997; Piccini et al., 1999), and methods for neuronal stabili-
zation before transplantation are desirable. In addition,
pharmacological downregulation of a recently described
neuronal-specific NF splice variant (Geist and Gutmann,
1996) could be tested for a possible enhancement of en-
dogenous Ras activity. Thus, investigations on the Ras-medi-
ated neuroprotection in vivo  may help to develop new
therapeutic strategies against neurodegenerative diseases.
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